GCM
KIN

Gruss Capital Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Gruss Capital Management’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-330,000
Closed -$1.14M – 70
2016
Q1 		$1.14M Hold
330,000
– – 0.35% 49
2015
Q4 		$1.12M Hold
330,000
– – 0.16% 76
2015
Q3 		$1.72M Hold
330,000
– – 0.14% 75
2015
Q2 		$2.25M Hold
330,000
– – 0.2% 61
2015
Q1 		$2.36M Buy
330,000
+30,000
+10% +$207K 0.28% 58
2014
Q4 		$2.23M Buy
+300,000
New +$2.54M 0.21% 71

Other funds holding KIN

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.13B AUM 47.25% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return